Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.

Kotecha, Payal Trupti; Godsland, Ian F; Crook, David; Stevenson, John C

Kotecha, Payal Trupti; Godsland, Ian F; Crook, David; Stevenson, John C.

Afiliação

Kotecha PT; Section of Metabolic Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
Godsland IF; Section of Metabolic Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.
Crook D; School of Health Sciences, University of Brighton, Brighton, UK.
Stevenson JC; National Heart and Lung Institute, Imperial College London, London, UK.

Clin Endocrinol (Oxf) ; 92(4): 303-311, 2020 04.

Article em En | MEDLINE | ID: mdl-31925799

Assuntos

Estradiol; Pós-Menopausa; Apolipoproteínas; HDL-Colesterol; Método Duplo-Cego; Terapia de Reposição de Estrogênios; Estrogênios; Feminino; Humanos; Lipídeos; Lipoproteínas HDL; Noretindrona; Acetato de Noretindrona; Norpregnenos

Palavras-chave

17-beta oestradiol; HDL subfractions; apolipoprotein; continuous combined HRT; tibolone; very low-density lipoprotein

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pós-Menopausa / Estradiol Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google